Clinical trial · Interventional
Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are interested here in the contribution of a new prostate cancer screening method and, more specifically, in the new and somewhat futuristic approach of artificial intelligence in the development of new, more accurate algorithms that make it possible to rethink the benefits of mass generalisation of prostate biopsies. Main objective The main objective of this research is to use artificial intelligence and an associated algorithm to identify new indicators that would make it possible to avoid a prostate biopsy in patients with an initial suspicion of prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer (Adenocarcinoma) | Malignant Prostate Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PROSTia test | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Prostia test
- description
- patients who responded to the PROSTia questionnaire
- interventionNames
- Other: PROSTia test
Primary outcomes (8)
- measure
- sensitivity
- timeFrame
- Immediately after to notification of prostate biopsy results.
- description
- Measuring the sensitivity of the test in comparison with the results of prostate biopsies
- measure
- specificity
- timeFrame
- Immediately after to notification of prostate biopsy results.
- description
- Measuring the specificity of the test in comparison with the results of prostate biopsies
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Patients followed up at the Nancy CHRU in the Urology Department and eligible for a prostate biopsy in search of prostate cancer, taking into account an increase in PSA, PSA density, lesion on MRI. * Person who has received full information about the organisation of the research and has not objected to their participation and the use of their data. * Adult male over 18 years of age - Patient affiliated to or benefiting from a social security scheme - Patient who understands French and is able to fill in a self-administered questionnaire or who has the possibility to be assisted in filling it in. Exclusion criteria: * Patients who have already had a prostate biopsy * Patients under court protection, guardianship or trusteeship * Patients deprived of liberty by judicial or administrative decision
References
Publications (0)
Data not yet available